SGLT3 modulation could have implications for obesity (Soták et al., 2021), metabolic syndrome, and attention-deficit hyperactivity disorder (ADHD) (Nevola et al., 2023). The gene discussed is SLC5A4; the disease is attention deficit-hyperactivity disorder.